Analyst Consensus ?
ConsensusBuy31 ratings
Bullish2477.4%
Neutral722.6%
Bearish00.0%
Coherent, Inc. · COHR · FY2024 Q4 · Calendar Q3 2024
Coherent: Datacom Growth Advances as Portfolio Review Begins
The supplied analysis supports a constructive but conditional view: resilient AI-related datacom demand and higher-speed transceiver growth remain important drivers, while the portfolio review, margin improvement and debt reduction must execute to convert that demand into durable earnings growth.
Reported After market closeNYSETechnology
$45.87B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$0.61
Consensus $0.60
EPS surprise
+1.7%
Reported versus consensus
Reported revenue
$1.31B
Consensus $1.28B
Revenue surprise
+3.0%
Reported versus consensus
Market reaction
event-close to next-session close
Stock move
+7.5%
Event window
SPY move
+0.2%
Same window
Abnormal move
+7.3%
Stock minus SPY
Volume
2.6×
Versus trailing sessions
Subsequent drift
-1.8%
Up to 20 sessions
COHRSPY benchmark
Ask FN2 about COHR FY2024 Q4
Transcript, numbers and history already loaded
Why did COHR rise 7.5% after beating EPS estimates in FY2024 Q4?What changed in COHR's guidance and outlook in FY2024 Q4?Give me the bull and bear case for COHR after FY2024 Q4 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior-quarter analysis, management shifted emphasis from resolving a temporary yield issue and raising guidance to a formal four-category portfolio review, investment reallocation, pricing optimization and continued capacity expansion. Datacom momentum remained the central growth theme, while guidance was maintained rather than raised.
Guidance delta
Management maintained its guidance while emphasizing continued investment in high-growth datacom capacity and margin improvement.
Key takeaways
- Q4 revenue rose 8.7% sequentially and 9.1% year over year, according to the supplied analysis.
- Datacom transceiver revenue grew 16% sequentially and 58% year over year, supported by 800G backlog and planned 1.6T ramps.
- Management is reallocating investment toward high-growth areas while pursuing pricing and cost actions to improve margins.
Management priorities
- Scale 800G, 400G ZR+/ZR and 1.6T transceiver capacity
- Use portfolio assessment to direct capital and operating resources
- Advance pricing optimization, product-cost reduction and leadership succession
Follow COHR with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$232.9Current
$52Low
$217.6Average
$455High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 18, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| B. Riley Securities | Neutral | Neutral | Maintain | Oct 15, 2026 |
| Rosenblatt | Buy | Buy | Maintain | Oct 13, 2026 |
| Deutsche Bank | Buy | Buy | Maintain | Sep 1, 2026 |
| Needham | Buy | Buy | Maintain | Aug 13, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Aug 13, 2026 |
| Jefferies | Buy | Buy | Maintain | Aug 13, 2026 |
| Raymond James | Strong Buy | Strong Buy | Maintain | Jul 2, 2026 |
| TD Cowen | Buy | Buy | Maintain | May 7, 2026 |
| Stifel | Buy | Buy | Maintain | May 5, 2026 |
| Citigroup | Buy | Buy | Maintain | Apr 21, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Apr 9, 2026 |
| Barclays | Overweight | Overweight | Maintain | Mar 3, 2026 |
| Susquehanna | Positive | Positive | Maintain | Jan 22, 2026 |
| B of A Securities | Neutral | Buy | Downgrade | Aug 14, 2025 |
| Northland Capital Markets | Outperform | Outperform | Maintain | Jun 2, 2025 |
| Benchmark | Buy | Buy | Maintain | May 8, 2025 |
| Craig-Hallum | Buy | Buy | Maintain | Nov 7, 2024 |
| UBS | Buy | Buy | Maintain | Aug 7, 2023 |
| Loop Capital | Buy | Buy | Maintain | May 11, 2023 |
| Cowen & Co. | Outperform | Outperform | Maintain | Feb 9, 2023 |
| William Blair | Perform | Market Perform | Maintain | Oct 17, 2022 |
| Berenberg | Hold | Buy | Downgrade | Jan 21, 2021 |
| Longbow Research | Neutral | Buy | Downgrade | Nov 12, 2020 |
| Piper Sandler | Overweight | Overweight | Maintain | May 28, 2020 |
| Goldman Sachs | Buy | Neutral | Upgrade | Apr 24, 2020 |
| PiperJaffray | Overweight | Overweight | Maintain | Dec 20, 2019 |
| Stifel Nicolaus | Buy | Buy | Maintain | May 1, 2019 |
| B. Riley FBR | Neutral | Neutral | Maintain | May 5, 2018 |
| Northcoast Research | Buy | Buy | Maintain | Oct 25, 2016 |
| Sidoti & Co. | Buy | Buy | Maintain | Jun 15, 2015 |
| Noble Financial | Buy | Hold | Upgrade | Jan 25, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $232.9. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Bernstein | Analyst unavailable | $350 | $292.21 | +50.3% | Sep 30, 2026 |
| Deutsche Bank | Analyst unavailable | $400 | $277.83 | +71.7% | Aug 31, 2026 |
| Stifel Nicolaus | Ruben Roy | $420 | $337.34 | +80.3% | Aug 13, 2026 |
| Raymond James | Analyst unavailable | $448 | $348.88 | +92.4% | Aug 13, 2026 |
| Needham | Ryan Koontz | $420 | $355.64 | +80.3% | Aug 13, 2026 |
| Jefferies | Analyst unavailable | $420 | $355.64 | +80.3% | Aug 13, 2026 |
| Raymond James | Analyst unavailable | $435 | $368.65 | +86.8% | Jul 2, 2026 |
| Morgan Stanley | Meta Marshall | $330 | $326 | +41.7% | May 7, 2026 |
| Northland Securities | Analyst unavailable | $230 | $323.58 | -1.2% | May 7, 2026 |
| Raymond James | Analyst unavailable | $371 | $329.34 | +59.3% | May 7, 2026 |
| Stifel Nicolaus | Analyst unavailable | $412 | $329.89 | +76.9% | May 5, 2026 |
| Redburn Partners | Mike Harrison | $455 | $319.71 | +95.4% | May 1, 2026 |
| Morgan Stanley | Analyst unavailable | $290 | $341.73 | +24.5% | Apr 20, 2026 |
| Morgan Stanley | Meta Marshall | $250 | $248.18 | +7.3% | Feb 23, 2026 |
| Northland Securities | Tim Savageaux | $170 | $204.12 | -27.0% | Feb 5, 2026 |
| Stifel Nicolaus | Analyst unavailable | $235 | $198.78 | +0.9% | Feb 5, 2026 |
| Barclays | Tom O'Malley | $235 | $211 | +0.9% | Feb 5, 2026 |
| Morgan Stanley | Meta Marshall | $190 | $228.51 | -18.4% | Jan 30, 2026 |
| Stifel Nicolaus | Ruben Roy | $220 | $197.26 | -5.5% | Jan 22, 2026 |
| Susquehanna | Christopher Rolland | $235 | $197.26 | +0.9% | Jan 22, 2026 |
| Barclays | Tom O'Malley | $215 | $184.11 | -7.7% | Jan 15, 2026 |
| Morgan Stanley | Meta Marshall | $180 | $175.2 | -22.7% | Dec 17, 2025 |
| Raymond James | Simon Leopold | $210 | $177.35 | -9.8% | Dec 5, 2025 |
| Needham | Analyst unavailable | $190 | $155.44 | -18.4% | Nov 6, 2025 |
| Susquehanna | Analyst unavailable | $160 | $155.44 | -31.3% | Nov 6, 2025 |
| Morgan Stanley | Meta Marshall | $150 | $155.44 | -35.6% | Nov 6, 2025 |
| Susquehanna | Christopher Rolland | $150 | $120.79 | -35.6% | Oct 22, 2025 |
| Barclays | Tom O'Malley | $135 | $116.35 | -42.0% | Oct 20, 2025 |
| Morgan Stanley | Analyst unavailable | $120 | $122.35 | -48.5% | Oct 10, 2025 |
| Barclays | Tom O'Malley | $110 | $114.01 | -52.8% | Aug 14, 2025 |
| Morgan Stanley | Analyst unavailable | $97 | $106.74 | -58.4% | Aug 4, 2025 |
| Northland Securities | Tim Savageaux | $85 | $76.78 | -63.5% | Jun 2, 2025 |
| Raymond James | Strong Buy | $91 | $76.71 | -60.9% | Mar 24, 2025 |
| Loop Capital Markets | Ananda Baruah | $120 | $93 | -48.5% | Nov 7, 2024 |
| Rosenblatt Securities | Mike Genovese | $105 | $98.44 | -54.9% | Oct 22, 2024 |
| B.Riley Financial | Dave Kang | $86 | $102.07 | -63.1% | Oct 18, 2024 |
| Needham | James Ricchiuti | $120 | $104.62 | -48.5% | Oct 14, 2024 |
| Bank of America Securities | Vivek Arya | $108 | $94.27 | -53.6% | Oct 4, 2024 |
| Susquehanna | Christopher Rolland | $120 | $88.91 | -48.5% | Oct 1, 2024 |
| Craig-Hallum | Richard Shannon | $85 | $74.39 | -63.5% | Aug 16, 2024 |
| Needham | James Ricchiuti | $84 | $73.96 | -63.9% | Aug 16, 2024 |
| Rosenblatt Securities | Mike Genovese | $84 | $74.05 | -63.9% | Aug 16, 2024 |
| Needham | Alex Henderson | $70 | $71.53 | -69.9% | Aug 15, 2024 |
| Bank of America Securities | Vivek Arya | $75 | $66.7 | -67.8% | Aug 12, 2024 |
| B.Riley Financial | Dave Kang | $77 | $60.62 | -66.9% | Apr 1, 2024 |
| Needham | James Ricchiuti | $72 | $60.62 | -69.1% | Apr 1, 2024 |
| Barclays | Tom O'Malley | $60 | $45.16 | -74.2% | Jan 16, 2024 |
| Needham | Jim Ricchiuti | $52 | $43.46 | -77.7% | Dec 15, 2023 |
| Needham | James Ricchiuti | $50 | $34.79 | -78.5% | Oct 11, 2023 |
| Needham | Jim Ricchiuti | $64 | $54.74 | -72.5% | Jun 20, 2023 |
| Morgan Stanley | Analyst unavailable | $45 | $35.41 | -80.7% | Dec 13, 2022 |
| Deutsche Bank | Analyst unavailable | $50 | $36.82 | -78.5% | Nov 28, 2022 |
| Barclays | Thomas O'Malley | $65 | $71.55 | -72.1% | Jan 12, 2022 |
| Bank of America Securities | Vivek Arya | $80 | $71.24 | -65.7% | Jan 10, 2022 |
| Craig-Hallum | Richard Shannon | $100 | $74.49 | -57.1% | Jan 4, 2022 |
| Morgan Stanley | Meta Marshall | $82 | $70.5 | -64.8% | Dec 15, 2021 |
| Cowen & Co. | Paul Silverstein | $94 | $66.57 | -59.6% | Dec 13, 2021 |
| Northland Securities | Tim Savageaux | $75 | $64 | -67.8% | Nov 10, 2021 |
| Deutsche Bank | Sidney Ho | $75 | $62.66 | -67.8% | Sep 1, 2021 |
| Stifel Nicolaus | John Marchetti | $82 | $64.38 | -64.8% | Aug 11, 2021 |
Track every rating change on COHR the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationCoherent, Inc. specializes in advanced laser technologies, offering a comprehensive suite of products that includes lasers, laser-based solutions, and complete systems. These are deployed across a spectrum of uses, from commercial and industrial operations to critical scientific research. The company's operations are distinctly segmented into two primary areas: laser sources for Original Equipment Manufacturers (OEMs) and industrial lasers alongside integrated systems. Coherent handles the entire lifecycle of its offerings, from conceptual design and manufacturing to global marketing and ongoing service.…
Historical context
All COHR earningsTechnology peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| WIT Wipro Limited | FY2027 Q2 · Calendar Q4 2026 | -25.0% | +3.9% | Wipro: AI pipeline expands as Q3 guidance stays narrow |
| TSM Taiwan Semiconductor Manufacturing Company Limited | FY2026 Q3 · Calendar Q4 2026 | +3.4% | -1.8% | TSMC beats Q3 guidance as AI demand drives fab expansion |
| ERIC Telefonaktiebolaget LM Ericsson (publ) | FY2026 Q3 · Calendar Q4 2026 | +28.6% | +11.8% | Ericsson Q3: 7% organic growth, resilient margins and AI-led demand |
| ASML ASML Holding N.V. | FY2026 Q3 · Calendar Q4 2026 | +20.4% | -3.9% | ASML: Record Q3, strong AI demand and broader capacity plans |
Latest beats and misses
Who reports nextBeat on EPS
Get the COHR recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2024-10-17T05:10:49.140638+00:00
- Polygon adjusted daily market bars · 2026-10-18T02:00:40.664879+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-18T02:00:40.662207+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-18. For educational purposes only; not investment advice.